Report cover image

Renal Failure Treatment

Published Jul 01, 2025
Length 282 Pages
SKU # GJOB20172366

Description

Global Renal Failure Treatment Market to Reach US$182.2 Billion by 2030

The global market for Renal Failure Treatment estimated at US$117.0 Billion in the year 2024, is expected to reach US$182.2 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Dialysis Treatment, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$89.3 Billion by the end of the analysis period. Growth in the Kidney Transplantation Treatment segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.9 Billion While China is Forecast to Grow at 12.2% CAGR

The Renal Failure Treatment market in the U.S. is estimated at US$31.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$39.2 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Renal Failure Treatment Market - Key Trends & Drivers Summarized

How Is the Renal Failure Landscape Shifting Toward Integrated and Personalized Care?
Renal failure, particularly end-stage renal disease (ESRD), represents the final progression of chronic kidney disease (CKD), where the kidneys can no longer perform essential filtration and regulatory functions. Patients with ESRD require renal replacement therapy (RRT), which includes dialysis or kidney transplantation. The increasing global incidence of ESRD-driven by chronic diseases such as diabetes and hypertension-is placing immense pressure on healthcare systems to optimize both acute and long-term management strategies. This shift is prompting a re-evaluation of renal care frameworks to enhance early diagnosis, care coordination, and post-treatment support.

Integrated nephrology care models that unify screening, pharmacologic management, dietary counseling, and timely dialysis initiation are gaining momentum. Early-stage interventions such as sodium-glucose cotransporter-2 (SGLT2) inhibitors are proving effective in delaying progression to renal failure, reducing proteinuria, and lowering cardiovascular risks. These agents are now being prescribed earlier in the CKD treatment journey to reduce future dialysis dependency. Additionally, mobile health platforms and remote monitoring tools are facilitating patient engagement, particularly for home-based dialysis or pre-transplant evaluations, improving outcomes and cost-efficiency.

Which Treatment Modalities Are Evolving to Meet Complex Patient Needs?
Dialysis remains the cornerstone of renal failure management, divided into hemodialysis (HD) and peritoneal dialysis (PD). Hemodialysis, performed at centers or increasingly in homes, is supported by innovations in dialysis machines, wearable technologies, and advanced filtration membranes. On-line hemodiafiltration (HDF), which combines convective and diffusive clearance, is gaining adoption for improved toxin removal. Home hemodialysis systems are now compact, portable, and connected, enabling personalized care with fewer complications and better quality of life.

Peritoneal dialysis is also witnessing a resurgence, especially in Asia-Pacific and Latin America, due to its cost-effectiveness and patient autonomy. Automated PD machines with remote data transmission and smart fluid management are enabling safer and more efficient self-care. Kidney transplantation remains the most definitive treatment, but organ shortages, immunosuppressive complications, and eligibility limitations restrict access. To expand the transplant pool, initiatives like paired kidney exchange, desensitization protocols, and normothermic machine perfusion for donor organs are being explored. Immunotherapy and regenerative approaches such as bioartificial kidneys are in preclinical stages, offering long-term potential for ESRD management.

Which Regional Systems and Patient Populations Are Reshaping Market Priorities?
High-income countries such as the U.S., Japan, and Western Europe have mature dialysis and transplant systems, but face challenges in cost containment and aging ESRD populations. These regions are focusing on shifting dialysis to the home setting, increasing the use of telehealth, and incorporating preventive nephrology services. The U.S. Medicare ESRD program continues to evolve with bundled payments and quality-based reimbursement that reward early referral and modality diversification. Europe is investing in wearable dialysis systems and expanding donor organ utilization through policy reforms.

Emerging economies are becoming focal points for market expansion due to rising CKD incidence and government investments in nephrology infrastructure. China’s national dialysis program, India’s Pradhan Mantri National Dialysis Program, and Latin America’s PPP models are all expanding treatment access. However, affordability remains a barrier, spurring demand for low-cost dialysis machines, reusable consumables, and generic immunosuppressants. Younger ESRD patients, often affected by congenital or autoimmune causes, represent a distinct subpopulation requiring lifelong, high-quality renal care. Their presence is increasing pressure on systems to balance cost, innovation, and equitable access.

What Factors Are Driving the Growth of the Renal Failure Treatment Market?
The growth in the renal failure treatment market is driven by the rising prevalence of ESRD, expansion of dialysis infrastructure, increasing transplantation rates, and innovation in early-stage CKD therapies. As CKD continues to advance undiagnosed in many patients, health systems are investing in screening programs and chronic care pathways to delay or manage renal failure. Home dialysis solutions, AI-powered dialysis planning tools, and wearable dialysis devices are making therapy more accessible and patient-friendly.

Transplantation is receiving a boost from organ preservation technologies, living donor advocacy, and government subsidies for post-transplant care. The development of nephroprotective agents, digital adherence platforms, and hybrid treatment centers is improving care quality across the CKD-ESRD continuum. Global funding initiatives, PPP models, and strategic alliances between medtech and pharma firms are enabling market entry into underserved regions. Together, these forces are propelling the renal failure treatment market toward a future defined by precision, accessibility, and integrated chronic disease management.

SCOPE OF STUDY:

The report analyzes the Renal Failure Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Treatment (Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment, Other Treatments); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -
  • AbbVie Inc.
  • Akebia Therapeutics, Inc.
  • Amgen Inc.
  • Asahi Kasei Corporation
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Calliditas Therapeutics AB
  • DaVita Inc.
  • Dialysis Clinic, Inc. (DCI)
  • Fresenius Medical Care AG & Co. KGaA
  • GSK plc
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • NIPRO Corporation
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Toray Industries, Inc.
AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

282 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tariff Impact on Global Supply Chain Patterns
Renal Failure Treatment – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Burden of Chronic Kidney Disease Spurs Demand for Advanced Therapies
Expansion of Hemodialysis Infrastructure Strengthens Business Case for Treatment Accessibility
Growth in Transplant Waitlists Throws the Spotlight on Alternative Renal Replacement Options
Adoption of Home Dialysis Technologies Expands Patient-Centered Care Models
Pharmaceutical Advancements in Erythropoiesis-Stimulating Agents Propel Treatment Innovation
Rising Prevalence of Diabetes and Hypertension Accelerates Market Penetration
Government Investments in Kidney Health Programs Generate Access to Early-Stage Interventions
Advancements in Peritoneal Dialysis Fluids Drive Adoption in Ambulatory Settings
Increased Availability of Wearable and Portable Dialysis Systems Enhances Treatment Flexibility
Telemedicine Integration Improves Monitoring and Chronic Renal Care Management
Expansion of Kidney Disease Screening Initiatives Supports Preventive Intervention Models
Strategic Collaborations Between Device Makers and Providers Foster Product Accessibility
Inclusion of Renal Disease in UHC Plans Strengthens Reimbursement Landscape
Development of Artificial Kidneys Generates Long-Term Disruption Opportunities
Digital Platforms for Patient Engagement Improve Therapy Compliance and Outcomes
Demand for Individualized Treatment Plans Drives Clinical Decision Support Tools
Public Awareness Campaigns Highlight Importance of Early Detection and Ongoing Care
Improved Cold Chain Logistics Accelerate Global Distribution of Renal Therapies
Clinical Trial Advancements in Combination Therapies Support Pipeline Expansion
Rise in Geriatric Population Sustains Need for Long-Term Renal Care Solutions
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Renal Failure Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Renal Failure Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 4: World 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Dialysis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Dialysis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 7: World 16-Year Perspective for Dialysis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Kidney Transplantation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Kidney Transplantation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 10: World 16-Year Perspective for Kidney Transplantation Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Drug Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Drug Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 13: World 16-Year Perspective for Drug Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 16: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 22: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: USA Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 28: USA 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: USA Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 31: USA 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 34: Canada 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 35: Canada Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 37: Canada 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
JAPAN
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 40: Japan 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 41: Japan Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 43: Japan 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
CHINA
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 44: China Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: China Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 46: China 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 47: China Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: China Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 49: China 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
EUROPE
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Renal Failure Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 52: Europe 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 55: Europe 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 58: Europe 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
FRANCE
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 59: France Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: France Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 61: France 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 62: France Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: France Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 64: France 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
GERMANY
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 67: Germany 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 68: Germany Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 70: Germany 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ITALY
TABLE 71: Italy Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 73: Italy 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 74: Italy Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 76: Italy 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
UNITED KINGDOM
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: UK Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 79: UK 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 80: UK Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: UK Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 82: UK 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SPAIN
TABLE 83: Spain Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 85: Spain 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 86: Spain Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Spain Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 88: Spain 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
RUSSIA
TABLE 89: Russia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 91: Russia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 92: Russia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Russia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 94: Russia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF EUROPE
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 100: Rest of Europe 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ASIA-PACIFIC
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Renal Failure Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
AUSTRALIA
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 110: Australia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 112: Australia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 113: Australia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Australia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 115: Australia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
INDIA
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 116: India Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: India Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 118: India 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 119: India Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: India Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 121: India 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SOUTH KOREA
TABLE 122: South Korea Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 125: South Korea Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: South Korea Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 127: South Korea 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Rest of Asia-Pacific Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
LATIN AMERICA
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 134: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Renal Failure Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 140: Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 142: Latin America 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ARGENTINA
TABLE 143: Argentina Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 146: Argentina Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Argentina Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 148: Argentina 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
BRAZIL
TABLE 149: Brazil Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 152: Brazil Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Brazil Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 154: Brazil 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
MEXICO
TABLE 155: Mexico Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 158: Mexico Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Mexico Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 160: Mexico 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Rest of Latin America Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 166: Rest of Latin America 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
MIDDLE EAST
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 167: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Renal Failure Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Renal Failure Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 173: Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 175: Middle East 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
IRAN
TABLE 176: Iran Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 178: Iran 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 179: Iran Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Iran Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 181: Iran 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
ISRAEL
TABLE 182: Israel Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 184: Israel 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 185: Israel Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: Israel Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 187: Israel 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
SAUDI ARABIA
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: Saudi Arabia Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 193: Saudi Arabia 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 194: UAE Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 196: UAE 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 197: UAE Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: UAE Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 199: UAE 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Rest of Middle East Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 205: Rest of Middle East 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
AFRICA
Renal Failure Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 206: Africa Recent Past, Current & Future Analysis for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Renal Failure Treatment by Treatment - Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 208: Africa 16-Year Perspective for Renal Failure Treatment by Treatment - Percentage Breakdown of Value Sales for Dialysis Treatment, Kidney Transplantation Treatment, Drug Therapy Treatment and Other Treatments for the Years 2014, 2025 & 2030
TABLE 209: Africa Recent Past, Current & Future Analysis for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Africa Historic Review for Renal Failure Treatment by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 211: Africa 16-Year Perspective for Renal Failure Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
IV. COMPETITION
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.